Medisola
PrivateLast Round
Series A
Apr 3, 2025
Total Funding Raised
$11.1M
Company Overview
Medisola operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series A round in April 2025.
Medisola is a food-tech company that provides personalized nutritional solutions and meal plans based on medical data and AI for preventative health and disease management.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Subscription Commerce, D2C Brands
Business Model
B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medisola Comparables
Compare Medisola with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eatmaple | 87% | |
| Eatmapl | 84% | |
| SallyCook | 82% |
For institutional investors. Book with your work email.
Medisola Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Medisola Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Premier Partners | Series A |
| Samsung Venture Investment | Series A |
| Redbadge Pacific | Series A |
| Samsung Venture Investment | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 105% MoM, reaching 33.7K.
- Apr 7, 2025
Developing ArchenX, an AI platform for diet planning and digital meal prescriptions.
For institutional investors. Book with your work email.
Medisola Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Medisola's valuation, stock price, and market status.
Is Medisola a public or private company?
Medisola is a private company.
What is the current stock price of Medisola?
Medisola is a private company, so its shares have no public market price. Caplight tracks Medisola's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Medisola worth (valuation)?
Valuation information for Medisola is not publicly available.
Can I buy Medisola stock?
Medisola shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Medisola's last funding round?
Medisola's most recent funding round was Series A on April 3, 2025.
Who are the main investors in Medisola?
Key investors in Medisola include Premier Partners, Samsung Venture Investment, Redbadge Pacific, Samsung Venture Investment.
Will Medisola IPO soon?
No public IPO plans have been announced for Medisola.
How can I track Medisola secondary market activity?
Caplight tracks bids, offers, and trades in Medisola's shares on secondary markets.